All In MedTech

FDA Clearance Tracker · P890055-S031

MEDSTREAM PROGRAMMABLE INFUSION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 12, 2013

Approved

Time to decision

756 days

Received Jan 18, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P890055-S031
Device name
MEDSTREAM PROGRAMMABLE INFUSION SYSTEM
Applicant location
Newton, MA
Received
Jan 18, 2011
Decided
Feb 12, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P890055

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE MEDSTREAM REFILL KIT AND O.R. PREP KIT. THE PMA SUPPLEMENT ALSO REQUESTED APPROVAL FOR STERILIZATION TO OCCUR AT STERIS ISOMEDIX SERVICES IN NORTHBOROUGH, MASSACHUSETTS AND KIT PACKAGING TO OCCUR AT CONTECH MEDICAL, INC., IN PROVIDENCE, RHODE ISLAND.

Source documents

Other decisions for Intera Oncology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.